These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7749383)

  • 1. Novel plasma kallikrein inhibitors of the benzamidine type.
    Stürzebecher J; Prasa D; Wikström P; Vieweg H
    Braz J Med Biol Res; 1994 Aug; 27(8):1929-34. PubMed ID: 7749383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glandular and plasma kallikrein by benzamidine derivatives.
    Stürzebecher J; Vieweg H; Prasa D
    Agents Actions Suppl; 1992; 38 ( Pt 1)():190-7. PubMed ID: 1466270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
    Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
    Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of isosteres of p-amidinophenylpyruvic acid. Inhibitors of trypsin thrombin, and pancreatic kallikrein.
    Geratz JD; Mar EC; Loeffler LJ; Fox LB
    J Med Chem; 1975 Mar; 18(3):287-92. PubMed ID: 1133820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study.
    Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M
    Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic inhibitors of serine proteinases. Part 26: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-arylsulfonylated 2-amino-4-(4-amidino-phenyl) butyric acid and 2-amino-5-amidinophenyl valeric acids (author's transl)].
    Stürzebecher J; Markwardt F; Vieweg H; Wagner G; Walsmann P
    Pharmazie; 1982 Apr; 37(4):281-3. PubMed ID: 6212947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1976 May; 19(5):634-9. PubMed ID: 1271404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of thrombin with benzamidine-based inhibitors.
    Stürzebecher J; Vieweg H; Wikström P; Turk D; Bode W
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):491-6. PubMed ID: 1515080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of activated protein C by benzamidine derivatives.
    Stürzebecher J; Prasa D; Taby O
    Thromb Res; 1993 Mar; 69(6):533-9. PubMed ID: 8503121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
    Kaiser B; Hauptmann J; Markwardt F
    Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
    Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
    Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts on action of synthetic thrombin inhibitors.
    Geratz JD; Tidwell RR
    Haemostasis; 1978; 7(2-3):170-6. PubMed ID: 350730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1975 May; 18(5):477-81. PubMed ID: 1171238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic inhibitors of serine proteinases. 31. The inhibition of trypsin, plasmin and thrombin by isomeric compounds of N alpha -arylsulfonylated omega-amidinophenyl-alpha-aminoalkylcarboxylic acid amides].
    Stürzebecher J; Markwardt F; Vieweg H; Wagner G; Walsmann P
    Pharmazie; 1984 Jun; 39(6):411-3. PubMed ID: 6237371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of trypsin, plasmin, thrombin and kallikrein by various esters of guanidino- and amidino-acids.
    Akashi H; Ariki T; Kato M; Kozaki Y; Irisawa T; Muramatu M
    Biol Pharm Bull; 1994 Mar; 17(3):446-8. PubMed ID: 8019515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear competitive inhibition of human tissue kallikrein by 4-aminobenzamidine and benzamidine and linear mixed inhibition by 4-nitroaniline and aniline.
    Sousa MO; Miranda TL; Costa EB; Bittar ER; Santoro MM; Figueiredo AF
    Braz J Med Biol Res; 2001 Jan; 34(1):35-44. PubMed ID: 11151026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.